Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients (NsG0202)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2010 by NsGene A/S.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Karolinska Institutet
Stockholm County Council, Sweden
Information provided by:
NsGene A/S
ClinicalTrials.gov Identifier:
NCT01163825
First received: July 14, 2010
Last updated: July 15, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):